PRPO - Precipio Inc Stock Price, Fair Value and News

$6.87+0.40 (+6.18%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PRPO Price Action

Last 7 days

0.2%


Last 30 days

16.8%


Last 90 days

2.7%


Trailing 12 Months

1.3%

PRPO RSI Chart

MayJunJulAugSepOctNovDec202520304050607080

PRPO Valuation

Market Cap

9.6M

Price/Earnings (Trailing)

-3.2

Price/Sales (Trailing)

0.54

EV/EBITDA

-4.96

Price/Free Cashflow

-83.46

PRPO Price/Sales (Trailing)

202220232024202502468101214

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PRPO Fundamentals

PRPO Revenue

Revenue (TTM)

17.6M

Rev. Growth (Yr)

15.56%

Rev. Growth (Qtr)

17.15%

2010201220142016201820202022202405M10M15M20M25M30M35M

PRPO Earnings

Earnings (TTM)

-3.0M

Earnings Growth (Yr)

56.98%

Earnings Growth (Qtr)

48.69%

20102012201420162018202020222024-35M-30M-25M-20M-15M-10M-5M0

PRPO Profitability

EBT Margin

-17.01%

Return on Equity

-25.12%

Return on Assets

-17.7%

Free Cashflow Yield

-1.2%

PRPO Investor Care

Shares Dilution (1Y)

4.38%

Diluted EPS (TTM)

-1.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2010201220142016201820202022202405M10M15M20M25M30M35M
Net sales
YearQ1Q2Q3Q4
202416.1M16.9M17.6M0
202310.1M11.3M13.6M15.4M
20229.1M9.3M9.5M9.8M
20216.7M7.3M7.4M8.7M
20204.7M5.1M6.1M6.1M
20193.6M3.8M4.0M4.1M
20182.5M3.2M3.7M3.4M
20172.0M1.7M1.5M2.0M
20161.4M1.6M1.7M1.9M
201519.3M13.0M9.2M1.9M
201426.4M25.9M23.3M24.8M
201331.6M29.9M28.6M27.5M
201231.7M33.1M32.8M31.5M
201122.1M24.7M28.5M32.0M
2010021.4M20.7M20.0M
200900022.0M
Get all data in R, Python etc through our Historical Stock Data APIs
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
 CEO
 WEBSITEprecipiodx.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES53

Precipio Inc Frequently Asked Questions


What is the ticker symbol for Precipio Inc? What does PRPO stand for in stocks?

PRPO is the stock ticker symbol of Precipio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Precipio Inc (PRPO)?

As of Thu Jan 30 2025, market cap of Precipio Inc is 9.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRPO stock?

You can check PRPO's fair value in chart for subscribers.

Is Precipio Inc a good stock to buy?

The fair value guage provides a quick view whether PRPO is over valued or under valued. Whether Precipio Inc is cheap or expensive depends on the assumptions which impact Precipio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRPO.

What is Precipio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jan 30 2025, PRPO's PE ratio (Price to Earnings) is -3.2 and Price to Sales (PS) ratio is 0.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRPO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Precipio Inc's stock?

In the past 10 years, Precipio Inc has provided -0.573 (multiply by 100 for percentage) rate of return.